Equities

Probi AB

Probi AB

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)31.60
  • Today's Change0.00 / 0.00%
  • Shares traded51.73k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 20 2024 16:48 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue628618658
OPERATING EXPENSES
Cost of revenue total407363370
Selling, general and admin. expenses, total172167143
Depreciation/amortization------
Unusual expense(income)------
Other operating expenses, total(0.04)(0.32)(1.69)
Total operating expense616568549
Operating income1151109
Other, net--(0.07)(0.12)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes1752107
Provision for income taxes0.561124
Net income after taxes174183
Minority interest------
Net income before extra. Items174183
Total extraordinary items------
Net income174183
Inc.avail. to common excl. extra. Items174183
Inc.avail. to common incl. extra. Items174183
EPS RECONCILIATION
Basic/primary weighted average shares111111
Basic/primary eps excl. extra items1.483.577.30
Basic/primary eps incl. extra items1.483.577.30
Dilution adjustment------
Diluted weighted average shares111111
Diluted eps excl. extra items1.483.577.30
Diluted eps incl. extra items1.483.577.30
COMMON STOCK DIVIDENDS
DPS - common stock primary issue1.301.301.30
Gross dividend - common stock151515
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental2.032.421.77
SUPPLEMENTAL INCOME
Depreciation, supplemental403024
Total special items------
NORMALISED INCOME
Normalized income before taxes1752107
Effect of special items on income taxes------
Income tax excluding impact of special items0.561124
Normalized income after tax174183
Normalized income avail. to common174183
Basic normalized EPS1.483.577.30
Diluted normalized EPS1.483.577.30
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.